A strategy of accuracy quantification by extending the concentration monitoring coverage based on online double collision energy of ultra-high performance liquid chromatography tandem mass spectrometry: The pharmacokinetics of Toddalia asiatica as a case study

• Published in: Journal of Chromatography A 2024-02, Vol.1716, p.464634, Article 464634
• Main Authors: Wang, Rui, Du, Kunze, Meng, Xue, Zhang, Qianqian, Wei, Wei, Li, Jin, Fang, Shiming, Chang, Yanxu
• Format: Article
• Language: English
• Subjects: absorption; case studies; energy; Online double collision energy; Pharmacokinetics; rats; tandem mass spectrometry; Toddalia asiatica; ultra-performance liquid chromatography; Upper limit of quantitation; Wide concentration monitoring coverage
• ISSN: 0021-9673
• DOI: 10.1016/j.chroma.2024.464634

•ODCE, a CMC expansion strategy, was developed.•CMC was extended unidirectionally.•ODCE was compatible with the concurrent determination of multiple compounds.•Improvement of ULOQ reached 50-fold. To facilitate the safety, efficacy and rationality of clinical application of traditional Chinese medicines (TCMs), pharmacokinetic research played an indispensable role. The key challenge during pharmacokinetic investigation lied at the substantial fluctuation of compound concentrations in the plasma over the course of absorption. Taking the pharmacokinetics of six compounds after administration of Toddalia asiatica (TA) as an example, an efficient strategy was established by introducing the online double collision energy (ODCE) into the quantification process applying ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS). During the analytical program, double collision energy (DCE) was optimized to establish the dual calibration curve (DCC) with large concentration monitoring coverage (CMC) for meeting the wide content range of certain target compounds. Method validation test was performed in terms of linearity, precision, sensitivity, matrix effect, recovery, etc. The results displayed that the CMC of todarolactone with high exposure in plasma was extended from 1.25–2,500 ng/mL to 1.25–125,000 ng/mL. Furthermore, a rapid UHPLC-MS/MS method integrated with ODCE was successfully applied to the determination of six compounds in rat plasma, revealing an extremely high plasma concentration of todarolactone (16,662 ng/mL). This strategy could expand the range of quantification while retaining extraordinary sensitivity. Consequently, it could be a fit-for-purpose strategy to quantify compounds over a wide concentration range for in vivo process monitoring.